ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation

This study is ongoing, but not recruiting participants.

Sponsored by: Mundipharma Research GmbH & Co KG
Information provided by: Mundipharma Research GmbH & Co KG
ClinicalTrials.gov Identifier: NCT00412100
  Purpose

The primary objective is to demonstrate that patients taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone.


Condition Intervention Phase
Pain
Drug: Oxycodone naloxone prolonged release tablets (OXN)
Phase III

MedlinePlus related topics:   Constipation   

Drug Information available for:   Naloxone    Naloxone hydrochloride    Oxycodone    Oxycodone hydrochloride   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   A Randomsied, Double-Blind, Double-Dummy, Parallel-Group Multicentre Study to Demonstrate Improvement in Symptoms of Constipation in Subjects With Non-Malignant Pain Taking Oxycodone Equivalent of 60-80 mg/Day as Oxycodone/Naloxone Prolonged Release Compared to Subjects Taking Oxycodone Prolonged Release Tablets Alone

Further study details as provided by Mundipharma Research GmbH & Co KG:

Primary Outcome Measures:
  • To demonstrate that subjects with moderate to severe non malignant pain taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone.

Study Start Date:   April 2006
Estimated Study Completion Date:   July 2008

Detailed Description:

Patients with a documented history of moderate to severe non-malignant pain that require around-the-clock opioid therapy will be randomised to an oxycodone or an oxycodone-naloxone treatment arm. The primary objective is to demonstrate that patients taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Male or female subjects at least 18 years or older with moderate to severe pain that requires around the clock opioid therapy. Subjects must report constipation caused or aggravated by opioids.

Exclusion Criteria:

  • Females who are pregnant or lactating.
  • Subjects with evidence of any clinically unstable disease or subjects with evidence of impaired liver/kidney function upon entry into the study.
  • Subjects with evidence of significant structural abnormalities of the gastrointestinal tract.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00412100

Sponsors and Collaborators
Mundipharma Research GmbH & Co KG

Investigators
Principal Investigator:     Oliver Lowenstein     Private Practice    
  More Information


Study ID Numbers:   2005-003510-15, OXN3006
First Received:   December 14, 2006
Last Updated:   April 29, 2008
ClinicalTrials.gov Identifier:   NCT00412100
Health Authority:   Germany: Ethics Commission

Keywords provided by Mundipharma Research GmbH & Co KG:
A randomised  
double-blind  
double-dummy  
parallel-group multicentre study to demonstrate improvement in symptoms of constipation  
Moderate to severe, chronic non-malignant pain  

Study placed in the following topic categories:
Signs and Symptoms
Signs and Symptoms, Digestive
Oxycodone
Constipation
Pain
Naloxone

Additional relevant MeSH terms:
Sensory System Agents
Therapeutic Uses
Physiological Effects of Drugs
Narcotic Antagonists
Central Nervous System Depressants
Narcotics
Analgesics
Peripheral Nervous System Agents
Central Nervous System Agents
Analgesics, Opioid
Pharmacologic Actions

ClinicalTrials.gov processed this record on November 20, 2008




Links to all studies - primarily for crawlers